Donoghue Forlines’s Humana HUM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$3.29M Buy
+8,275
New +$2.36M 0.85% 35
2025
Q4
Sell
-7,938
Closed -$2.07M 129
2025
Q3
$2.07M Buy
+7,938
New +$2.09M 0.64% 48
2023
Q3
Sell
-2,404
Closed -$1.07M 254
2023
Q2
$1.07M Sell
2,404
-64
-3% -$32.2K 0.34% 72
2023
Q1
$1.2M Buy
2,468
+30
+1% +$14.8K 0.43% 65
2022
Q4
$1.25M Buy
+2,438
New +$1.28M 0.44% 67

Other funds holding HUM

Donoghue Forlines's HUM Position: Q2 2026 in Review

Donoghue Forlines opened a new position in Humana (HUM) in Q2 2026: 8,275 shares worth $3.29M. The stake represents 0.85% of the portfolio and ranks #35 among its holdings. This is a return to the name: Donoghue Forlines previously reported a position in HUM as recently as Q3 2025.

Donoghue Forlines first reported a position in HUM in Q4 2022 and has held it in 5 quarters since. 924 funds tracked by Wall St. Rank hold HUM as of Q2 2026.

  • Donoghue Forlines held 8,275 shares of Humana worth $3.29M as of Q2 2026.
  • Humana was a new Donoghue Forlines position in Q2 2026.
  • Humana made up 0.85% of Donoghue Forlines's portfolio in Q2 2026, its #35 holding.
  • Donoghue Forlines first reported a position in Humana in Q4 2022 and has held it in 5 quarters since.
  • 924 funds tracked by Wall St. Rank held Humana as of Q2 2026.

Based on Donoghue Forlines's 13F filing for Q2 2026, filed 7 Aug 2026.